The estimated Net Worth of Charles Miner is at least $863 millier dollars as of 26 June 2018. Charles Miner owns over 15,000 units of Misonix Inc stock worth over $862,550 and over the last 19 years he sold MSON stock worth over $0. In addition, he makes $0 as Independent Director at Misonix Inc.
Charles has made over 4 trades of the Misonix Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 15,000 units of MSON stock worth $39,900 on 26 June 2018.
The largest trade he's ever made was exercising 15,000 units of Misonix Inc stock on 26 June 2018 worth over $39,900. On average, Charles trades about 3,167 units every 88 days since 2005. As of 26 June 2018 he still owns at least 32,500 units of Misonix Inc stock.
You can see the complete history of Charles Miner stock trades at the bottom of the page.
Dr. Charles Miner, III, is Independent Director of the company. Dr. Miner currently practices internal medicine in Darien, Connecticut and is employed by Stamford Health Medical Group. He is also a director of Castle Connolly Private Health Partners, LLC and CEO of Castle Connolly Lifestream MD, LLC. Dr. Miner is on staff at Stamford and Norwalk Hospitals and since 1982 has held a teaching position at Columbia Presbyterian Hospital. Dr. Miner received his M.D. from the University of Cincinnati College of Medicine in 1979 and received a Bachelor of Science from Lehigh University in 1974. Dr. Miner is an experienced physician and teacher in the medical field. He serves on the board of The Stamford Hospital Foundation Board. The Board believes his experience as a medical doctor and his corporate experience qualifies him to serve as a Director.
Charles Miner is 66, he's been the Independent Director of Misonix Inc since 2005. There are no older and 2 younger executives at Misonix Inc.
Charles's mailing address filed with the SEC is 1938 New Hwy, Farmingdale, NY 11735, USA.
Over the last 21 years, insiders at Misonix Inc have traded over $4,371,211 worth of Misonix Inc stock and bought 1,536,334 units worth $6,620,934 . The most active insiders traders include Stavros G. Vizirgianakis, Gary Gelman et Michael A Jr Mcmanus. On average, Misonix Inc executives and independent directors trade stock every 29 days with the average trade being worth of $378,885. The most recent stock trade was executed by Sharon W Klugewicz on 20 May 2020, trading 825 units of MSON stock currently worth $10,032.
Misonix, Inc. is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company's history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients.
Misonix Inc executives and other stock owners filed with the SEC include: